arrow
S

Silviu Sbiera

university of wurzburg
H指数:38
被引数:6,657

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AD08 Tumour-associated macrophage heterogeneity in adrenocortical adenomas and carcinomas: evidence for cortisol-dependent and sex-specific polarisation

AD08 肾上腺皮质腺瘤和腺癌中肿瘤相关巨噬细胞异质性:皮质醇依赖性和性别特异性极化的证据

2026-08-270
OAAI
OC12.5 - LBA_ECE_1391 - Characterisation of tumour-associated macrophages across adrenocortical adenomas and carcinomas: evidence for cortisol-driven and sex-specific polarisation

OC12.5 - LBA_ECE_1391 - 肾上腺腺瘤和癌中肿瘤相关巨噬细胞的特征分析:皮质醇驱动和性别特异性极化的证据

2026-08-100
OAAI
OC3.1 - ECE_1630 - Copy number variations define distinct genetic profiles and predict recurrence risk in Cushing's disease

OC3.1 - ECE_1630 - 拷贝数变异定义了库欣病的独特遗传谱并预测复发风险

2026-08-100
OAAI
OC7.3 - ECE_1415 - Glucocorticoid inhibition enables mono- and bispecific CAR-T cells to overcome immunotherapeutic resistance in adrenocortical carcinoma

OC7.3 - ECE_1415 - 糖皮质激素抑制使单特异性及双特异性CAR-T细胞能够克服肾上腺皮质癌的免疫治疗耐药性

2026-08-100
OAAI
Immunohistochemistry-guided analyses of steroidogenesis in primary bilateral macronodular adrenal hyperplasia

免疫组化指导下的原发性双侧大结节性肾上腺皮质增生中的类固醇生成分析

2026-01-010
PRE
Therapeutic potential of adavosertib (AZD1775), a WEE1 kinase inhibitor, in advanced adrenocortical carcinoma: focus on molecular changes

阿达沃塞替(Adavosertib, AZD1775)作为一种WEE1激酶抑制剂,在晚期肾上腺皮质癌中的治疗潜力:聚焦分子变化

2025-09-010
OAAI
Cover Image, Volume 45, Issue 6

封面图片,卷45,第6期

2025-06-240
OA